MicroRNAs in drug addiction: Current status and future perspectives

被引:13
|
作者
Zhao, Yue [1 ,2 ,3 ]
Qin, Feng [1 ,2 ,3 ]
Han, Shuang [1 ,2 ,3 ]
Li, Shu [1 ,2 ,3 ]
Zhao, Ying [1 ,2 ,3 ]
Wang, Hongbo [4 ]
Tian, Jingwei [4 ]
Cen, Xiaobo [1 ,2 ,3 ]
机构
[1] Sichuan Univ, Natl Chengdu Ctr Safety Evaluat Drugs, West China Hosp, State Key Lab Biotherapy, Keyuan Rd 4,Gaopeng St, Chengdu 610041, Peoples R China
[2] Sichuan Univ, Canc Ctr, West China Hosp, Keyuan Rd 4,Gaopeng St, Chengdu 610041, Peoples R China
[3] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China
[4] Yantai Univ, Collaborat Innovat Ctr Adv Drug Delivery Syst & B, Minist Educ, Yantai 264005, Peoples R China
基金
中国国家自然科学基金;
关键词
microRNAs (miRNAs); Drug addiction; Neuroadaptation; Biomarker; MU-OPIOID RECEPTOR; MEDIATED DOWN-REGULATION; POSTTRANSCRIPTIONAL REGULATION; ALCOHOL EXPOSURE; BDNF EXPRESSION; GABAERGIC NEUROTRANSMISSION; GLUCOCORTICOID-RECEPTOR; EXTRACELLULAR VESICLES; ALZHEIMERS-DISEASE; ADULT NEUROGENESIS;
D O I
10.1016/j.pharmthera.2022.108215
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug addiction is a chronic and relapsing brain disorder characterized by compulsive drug seeking and continued drug use despite adverse consequences. The high prevalence and social burden of addiction is indisputable; however, the available intervention is insufficient. Abnormal gene expression is observed in reward-related brain regions in animal models of addiction. The modulation of gene expression and aberrant adaptation of neural networks attribute to the changes in brain function under repeated exposure to addictive drugs. The emerging recognition of the role of microRNA (miRNA) provides new insights into many biological and pathological processes in the central nervous system. Considerable studies have demonstrated that miRNAs are strong modulators of posttranscriptional gene expression in drug addiction. Here, we provide an overview of miRNAs, followed by evidence for aberrant miRNA expression and regulatory roles of miRNAs in drug addiction as well as neuroadaptation. We concluded by providing our perspectives that miRNAs have the potential as novel therapeutic targets for drug addiction. (c) 2022 Published by Elsevier Inc.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Immunotherapy: Current Status and Future Perspectives
    Floudas, Charalampos S.
    Brar, Gagandeep
    Greten, Tim F.
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (04) : 1030 - 1040
  • [22] Pharmacogenomics: current status and future perspectives
    Munir Pirmohamed
    Nature Reviews Genetics, 2023, 24 : 350 - 362
  • [23] UMIN - Current status and future perspectives
    Kiuchi, T
    Igarashi, T
    MEDINFO 2004: PROCEEDINGS OF THE 11TH WORLD CONGRESS ON MEDICAL INFORMATICS, PT 1 AND 2, 2004, 107 : 1068 - 1072
  • [24] THE ONCOGENES - CURRENT STATUS AND FUTURE PERSPECTIVES
    KOUYOUMDJIAN, JC
    FEUILHADE, F
    RYMER, JC
    RODRIGUES, LEA
    REVISTA BRASILEIRA DE MEDICINA, 1988, 45 (05) : 143 - 149
  • [25] Bedaquiline: Current status and future perspectives
    Khoshnood, Saeed
    Goudarzi, Mehdi
    Taki, Elahe
    Darbandi, Atieh
    Kouhsari, Ebrahim
    Heidary, Mohsen
    Motahar, Moloudsadat
    Moradi, Melika
    Bazyar, Hadi
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 25 : 48 - 59
  • [26] Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
    Chen, D.
    Frezza, M.
    Schmitt, S.
    Kanwar, J.
    Dou, Q. P.
    CURRENT CANCER DRUG TARGETS, 2011, 11 (03) : 239 - 253
  • [27] Microfluidic strategies for natural products in drug discovery: Current status and future perspectives
    Qing, Lin-Sen
    Wang, Tian-Tian
    Luo, Han-Yue
    Du, Jia-Lan
    Wang, Run-Yue
    Luo, Pei
    TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2023, 158
  • [28] Sibutramine: current status as an anti-obesity drug and its future perspectives
    Sharma, Bikash
    Henderson, David C.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (12) : 2161 - 2173
  • [29] Correction to: Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics
    Young Hee Choi
    Hyo-Kyung Han
    Journal of Pharmaceutical Investigation, 2019, 49 (1) : 201 - 201
  • [30] Therapeutic targeting of microRNAs: current status and future challenges
    Li, Zhonghan
    Rana, Tariq M.
    NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (08) : 622 - 638